Blog
Weekly biotech market analysis, catalyst previews, and investing insights.
Biotech stocks are driven by catalysts. From PDUFA dates to AdCom meetings, here are the five types of events that move biotech stocks the most and how to position around them.
Read moreA biotech company is only as valuable as its pipeline. Learn the systematic framework professional analysts use to evaluate drug candidates, assess probability of success, and estimate peak sales potential.
Read moreThe FDA approval process is the single biggest determinant of biotech stock returns. Learn how each phase works, what the key milestones are, and how to evaluate approval probability as an investor.
Read moreIntroducing ClinicalInvestor — a free platform that tracks FDA catalysts, breaks down clinical trial data, and helps retail investors navigate the complex world of biotech stocks.
Read moreGet blog posts delivered to your inbox
Weekly biotech analysis and catalyst previews. No spam, unsubscribe anytime.
Subscribe free